Amgen Plans $650M Puerto Rico Manufacturing Expansion Creating 750 Jobs

Amgen Inc. is significantly expanding its U.S. manufacturing capacity with a $650 million investment in its Juncos, Puerto Rico, facility, expected to create approximately 750 jobs and enhance biologics production through advanced technology integration. This expansion is part of a broader campaign including a $900 million Ohio facility upgrade, a $1 billion factory expansion in North Carolina, and a $600 million science and innovation center in California, reflecting a strong commitment to reshoring and supply chain resilience. The company credits pro-growth policies from the Trump administration, including the Tax Cuts and Jobs Act of 2017 and the One Big Beautiful Bill Act of 2025, for supporting these investments. Amgen has invested over $40 billion in domestic manufacturing and research and development since 2017, aiming to strengthen America's leadership in biotechnology and create high-quality jobs. Despite robust revenue growth, Amgen faces financial challenges such as increased operating expenses and ongoing litigation related to tax liabilities. CEO Robert Bradway emphasized that these expansions will better serve patients and bolster global supply chain resilience.